Profit and Loss Results Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
580.00
510.00
472.00
424.00
386.00
366.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
580.00
510.00
472.00
424.00
386.00
366.00
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
-4.00
-13.00
3.00
-8.00
10.00
Raw Materials Consumed
284.00
245.00
232.00
193.00
191.00
164.00
Power & Fuel Cost
11.00
10.00
8.00
7.00
8.00
7.00
Employee Cost
102.00
93.00
79.00
63.00
58.00
51.00
Operating Expenses
23.00
18.00
16.00
15.00
16.00
17.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
23.00
18.00
16.00
24.00
26.00
20.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
3.00
2.00
2.00
1.00
3.00
2.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
480.00
421.00
376.00
337.00
320.00
298.00
Operating Profit (PBDIT) excl Other Income
99.00
89.00
95.00
87.00
65.00
67.00
Other Income
34.00
22.00
9.00
5.00
11.00
5.00
Operating Profit (PBDIT)
134.00
111.00
105.00
92.00
76.00
72.00
Interest
1.00
2.00
1.00
1.00
2.00
3.00
Profit before Depriciation and Tax
132.00
109.00
104.00
91.00
74.00
68.00
Depreciation
10.00
9.00
8.00
7.00
7.00
6.00
Profit Before Taxation & Exceptional Items
122.00
100.00
95.00
83.00
67.00
62.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
122.00
100.00
95.00
83.00
67.00
62.00
Provision for Tax
28.00
27.00
26.00
21.00
15.00
13.00
Profit After Tax
93.00
72.00
69.00
62.00
51.00
48.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
417.00
348.00
282.00
220.00
176.00
131.00
Profit Available for appropriations
510.00
421.00
351.00
282.00
227.00
180.00
Appropriations
510.00
421.00
351.00
282.00
227.00
180.00
Equity Dividend (%)
18.00%
15.00%
15.00%
15.00%
15.00%
15.00%
Earnings Per Share
46.58
36.40
34.63
31.08
25.72
24.36
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 13.76% vs 8.09% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 12.00% vs -6.57% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is -27.84% vs 39.89% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 27.99% vs 5.11% in Mar 2023
Compare Profit and Loss Results of Lincoln Pharma.
Figures in Rs cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
580.00
10,334.00
-9,754.00
-94.39%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
580.00
10,334.00
-9,754.00
-94.39%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
-94.00
89.00
94.68%
Raw Materials Consumed
284.00
3,263.00
-2,979.00
-91.30%
Power & Fuel Cost
11.00
129.00
-118.00
-91.47%
Employee Cost
102.00
2,274.00
-2,172.00
-95.51%
Operating Expenses
23.00
210.00
-187.00
-89.05%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
23.00
928.00
-905.00
-97.52%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
134.00
-131.00
-97.76%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
480.00
7,798.00
-7,318.00
-93.84%
Operating Profit (PBDIT) excl Other Income
99.00
2,536.00
-2,437.00
-96.10%
Other Income
34.00
280.00
-246.00
-87.86%
Operating Profit (PBDIT)
134.00
2,817.00
-2,683.00
-95.24%
Interest
1.00
35.00
-34.00
-97.14%
Profit before Depriciation and Tax
132.00
2,782.00
-2,650.00
-95.26%
Depreciation
10.00
398.00
-388.00
-97.49%
Profit Before Taxation & Exceptional Items
122.00
2,384.00
-2,262.00
-94.88%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
122.00
2,399.00
-2,277.00
-94.91%
Provision for Tax
28.00
457.00
-429.00
-93.87%
Profit After Tax
93.00
1,926.00
-1,833.00
-95.17%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
417.00
8,012.00
-7,595.00
-94.80%
Profit Available for appropriations
510.00
9,925.00
-9,415.00
-94.86%
Appropriations
510.00
9,925.00
-9,415.00
-94.86%
Equity Dividend (%)
18%
0%
18.00
Earnings Per Share
46.58
47.75
-1.17
-2.45%
Profit And Loss - Net Sales
Net Sales 580.55 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 13.76% vs 8.09% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 99.91 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 12.00% vs -6.57% in Mar 2023
Profit And Loss - Interest
Interest 1.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -27.84% vs 39.89% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 93.30 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 27.99% vs 5.11% in Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
